Not Tagged
Not Tagged
['leukemia', 'myeloid', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'leusm', 'novo ']
#ash22 #leusm ihlow for westermann: taml no longer categories as distinct subgroup in who/icc 2022. this study looked at outcomes of 225 with taml vs 908 with de novo aml. taml more freq had complex karyotype or other cytogen abnormalities. prior tx for solidca in 61%, 31% hemeca 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)